Sustainability Report

Overview

The report presents Envision Pharma Group's 2024 sustainability performance across people, stakeholder impact, climate action and governance. It reports 1,365 year-end employees and 85% renewable electricity consumption. Climate disclosures include 12 tCO2e Scope 1, 132 tCO2e location-based Scope 2, 27 tCO2e market-based Scope 2, and 10,377 tCO2e Scope 3, alongside SBTi-validated reduction targets. The report also documents double materiality, GRI reporting in accordance, UN Global Compact participation, and AA1000 Type 2 moderate assurance for Scope 1 and 2 data.

Document

Report type: Sustainability Report
Class: Dedicated
Scope: Full report
Fiscal year: 2024
Period: 1 January 2024 – 31 December 2024
Language: English
Pages
File size
Restatement: Disclosed

Standards

GRI
SASB
TCFD
ISSB
ESRS
Integrated Reporting Framework
GHG Protocol
EU Taxonomy
CDP
Other

Commitments

UN Global Compact
UN Guiding Principles
Science Based Targets initiative

Ratings

GRI level
SBTi status
CDP score

Materiality

Assessment
Basis
Matrix

Assurance

Provider
Standard
Scope
Statement included
Metrics assured

Data Services

Turn sustainability reports into a dataset built for your research.

From bulk PDFs to structured indicators and machine-readable documents.

View services

Overview